Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass. Data from IFSO-European Chapter Center of Excellence Program.

John Melissas1, Konstantinos Stavroulakis2, Vassilis Tzikoulis2

  • 1Bariatric Unit, Heraklion University Hospital, 164 Erythreas str, 71409, Heraklion, Greece. melissas@uoc.gr.

Obesity Surgery
|October 21, 2016
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Bariatric Surgery Motivation Questionnaire: A Validated Tool for Preoperative Assessment in Persian Population.

Obesity facts·2026
Same author

Two Case Reports of Adrenal Myelolipoma: Insights into a Rare and Benign Mass.

Case reports in oncology·2026
Same author

Food Consumption by Processing Levels in Adults Two or More Years After Sleeve Gastrectomy: Associations with Surgical Outcomes and Eating Behaviors.

Obesity surgery·2026
Same author

Anemia Following One Anastomosis Gastric Bypass: A Comparative Study of Diabetic and Non-Diabetic Patients.

Obesity surgery·2026
Same author

Impact of high-intensity interval training vs. moderate-intensity continuous training combined with strength training on physical and metabolic outcomes in post-bariatric surgery patients with sarcopenic obesity.

BMC musculoskeletal disorders·2026
Same author

Association of nailfold capillaroscopic features with cardiac block and arrhythmias due to systemic sclerosis-related primary heart involvement.

Reumatologia·2026

Sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGBP) show low complication rates. RYGBP offers superior excess weight loss and better remission of comorbidities in the first five years post-surgery.

Area of Science:

  • Bariatric surgery outcomes
  • Comparative effectiveness research
  • Surgical innovation

Background:

  • Sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGBP) are common bariatric procedures.
  • Centers of Excellence (COE) in bariatric surgery aim to standardize and improve patient care.
  • Comparative data on these procedures from high-volume centers is crucial for clinical decision-making.

Purpose of the Study:

  • To compare the outcomes of sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGBP).
  • To evaluate complications, mortality, readmissions, and reoperations for both procedures.
  • To assess weight loss and comorbidity remission rates following SG versus RYGBP.

Main Methods:

  • Retrospective comparison of 6413 SGs and 10,622 RYGBPs performed between January 2010 and December 2014.
Keywords:
Bariatric surgeryCenter of ExcellenceJohn Melissas and Konstantinos Stavroulakis contributed equally in this article.Morbid obesityRoux-en-Y gastric bypassSleeve gastrectomy

Related Experiment Videos

  • Procedures were conducted in institutions participating in the IFSO-European Chapter, Center of Excellence (COE) program.
  • Analysis included at least 12-month follow-up data.

    • Main Results:

    • SG had a significantly lower early postoperative complication rate (2.12%) compared to RYGBP (3.02%).
    • Mortality and readmission rates were low for both procedures.
    • RYGBP demonstrated significantly better excess weight loss and higher remission rates for diabetes, hypertension, dyslipidemia, and sleep apnea in the first five years.

    Conclusions:

    • Both SG and RYGBP are safe bariatric procedures with low rates of complications, mortality, readmissions, and reoperations.
    • RYGBP resulted in superior weight loss and comorbidity resolution compared to SG within the first five postoperative years.